| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1021/JM058240I |
| P698 | PubMed publication ID | 16821762 |
| P2093 | author name string | Björn M Nilsson | |
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4023-4034 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | 5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents | |
| P478 | volume | 49 |
| Q37789738 | 5-HT2C receptor modulators: a patent survey |
| Q28575935 | 5-Hydroxytryptamine potentiates neurogenic contractions of rat isolated urinary bladder through both 5-HT7 and 5-HT2C receptors |
| Q39587382 | A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat. |
| Q46792023 | Design, synthesis, and biological evaluation of novel alkenylthiophenes as potent and selective CB1 cannabinoid receptor antagonists |
| Q42800304 | Design, synthesis, and pharmacology of fluorescently labeled analogs of serotonin: application to screening of the 5-HT2C receptor |
| Q39768889 | Discovery and development of 5-HT(₂C) receptor agonists for obesity: is there light at the end of the tunnel? |
| Q24641896 | Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction |
| Q37015833 | Effect of (-)-trans-PAT, a novel 5-HT2C receptor agonist, on intake of palatable food in mice |
| Q46230494 | Effects of systemic and intra-nucleus accumbens 5-HT2C receptor compounds on ventral tegmental area self-stimulation thresholds in rats. |
| Q46240693 | Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles |
| Q47738255 | Evidence for a role of 5-HT2C receptors in the motor aspects of performance, but not the efficacy of food reinforcers, in a progressive ratio schedule. |
| Q38089855 | Genome-wide association studies for the identification of biomarkers in metabolic diseases |
| Q30478847 | HTS and rational drug design to generate a class of 5-HT(2C)-selective ligands for possible use in schizophrenia |
| Q24658013 | Pharmacological targeting of the serotonergic system for the treatment of obesity |
| Q42553427 | RNA editing of the serotonin 2C receptor and expression of Galpha(q) protein: genetic mouse models do not support a role for regulation or compensation |
| Q34332000 | Rational Drug Design Leading to the Identification of a Potent 5-HT(2C) Agonist Lacking 5-HT(2B) Activity |
| Q53251686 | Regioselective alkylation of 1,3,4,5-tetrahydrobenzo[d]azepin-2-one and biological evaluation of the resulting alkylated products as potentially selective [Formula: see text] agonists. |
| Q34413008 | Risperidone-induced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2C receptor gene |
| Q47588598 | Role of impulsivity and reward in the anti-obesity actions of 5-HT2C receptor agonists |
| Q34962263 | Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action |
| Q42633021 | Selective serotonin receptor stimulation of the medial nucleus accumbens differentially affects appetitive motivation for food on a progressive ratio schedule of reinforcement |
| Q28289039 | Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT(2A) receptors |
| Q34655896 | The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues |
| Q35837700 | The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control |
| Q35823591 | We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders. |
Search more.